JP2008535836A5 - - Google Patents

Download PDF

Info

Publication number
JP2008535836A5
JP2008535836A5 JP2008505285A JP2008505285A JP2008535836A5 JP 2008535836 A5 JP2008535836 A5 JP 2008535836A5 JP 2008505285 A JP2008505285 A JP 2008505285A JP 2008505285 A JP2008505285 A JP 2008505285A JP 2008535836 A5 JP2008535836 A5 JP 2008535836A5
Authority
JP
Japan
Prior art keywords
furosemide
ester
bumetanide
group
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008505285A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008535836A (ja
Filing date
Publication date
Priority claimed from US11/101,000 external-priority patent/US8722668B2/en
Priority claimed from US11/130,945 external-priority patent/US20060025387A1/en
Application filed filed Critical
Priority claimed from PCT/US2005/043177 external-priority patent/WO2006110187A2/en
Publication of JP2008535836A publication Critical patent/JP2008535836A/ja
Publication of JP2008535836A5 publication Critical patent/JP2008535836A5/ja
Pending legal-status Critical Current

Links

JP2008505285A 2005-04-07 2005-11-30 不安障害の治療のための方法および組成物 Pending JP2008535836A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11/101,000 US8722668B2 (en) 1998-12-23 2005-04-07 Methods and compositions for the treatment of neuropathic pain and neuropsychiatric disorders
US11/130,945 US20060025387A1 (en) 1998-12-23 2005-05-17 Compositions and methods for the treatment of disorders of the central and peripheral nervous systems
PCT/US2005/043177 WO2006110187A2 (en) 2005-04-07 2005-11-30 Methods and compositions for the treatment of anxiety disorders

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2008305450A Division JP2009102330A (ja) 2005-04-07 2008-11-28 不安障害の治療のための方法および組成物

Publications (2)

Publication Number Publication Date
JP2008535836A JP2008535836A (ja) 2008-09-04
JP2008535836A5 true JP2008535836A5 (https=) 2009-01-22

Family

ID=39789767

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2008505285A Pending JP2008535836A (ja) 2005-04-07 2005-11-30 不安障害の治療のための方法および組成物
JP2008305450A Pending JP2009102330A (ja) 2005-04-07 2008-11-28 不安障害の治療のための方法および組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2008305450A Pending JP2009102330A (ja) 2005-04-07 2008-11-28 不安障害の治療のための方法および組成物

Country Status (1)

Country Link
JP (2) JP2008535836A (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LT2523661T (lt) * 2010-01-15 2017-08-10 INSERM (Institut National de la Santé et de la Recherche Médicale) Nkcc inhibitoriai autizmo gydymui
WO2013087090A1 (en) 2011-12-12 2013-06-20 Auris Medical Ag Treatment of tinnitus through modulation of chloride co-transporter nkcc1 in the auditory system
TW201444788A (zh) * 2013-03-29 2014-12-01 Toray Industries 胺磺醯基苯衍生物及其醫藥用途
EP3388520A1 (en) * 2017-04-11 2018-10-17 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and pharmaceutical composition for reducing the expression of nkcc1 in a subject in need thereof
EP3768251A4 (en) * 2018-03-22 2022-12-07 Research Foundation Of The City University Of New York MODULATION OF NEURAL NKCC1 AS A THERAPEUTIC STRATEGY FOR SPASTICISM AND RELATED DISORDERS
CN116440079A (zh) * 2022-02-22 2023-07-18 北京多纳医药科技有限公司 经鼻给药脑靶向主动载药的布美他尼脂质体

Similar Documents

Publication Publication Date Title
US8008283B2 (en) Methods and compositions for the treatment of neuropsychiatric disorders
US8722668B2 (en) Methods and compositions for the treatment of neuropathic pain and neuropsychiatric disorders
JP6861764B2 (ja) 軸索再生および神経機能を促進するための方法および組成物
US20060025387A1 (en) Compositions and methods for the treatment of disorders of the central and peripheral nervous systems
TW518338B (en) Phosphinic acid amides as matrix metalloprotease inhibitors
KR20230149885A (ko) 폐암 치료에 사용하기 위한 3-(이미다졸-4-일)-4-(아미노)-벤젠설폰아마이드 tead 저해제와 egfr 저해제 및/또는 mek 저해제의 조합
JP2020143087A (ja) 障害を治療するための５ｈｔ作動薬
US20120234721A1 (en) Diuretic and diuretic-like compound analogs
AU2014262862B2 (en) Compounds for treatment of angiogenesis-mediated diseases
JP2008520740A (ja) Ｖｅｇｆ産生を阻害する活性因子としての置換されたフェノール
US20080021063A1 (en) Compositions and methods for modulating sirtuin activity
JP2009102330A (ja) 不安障害の治療のための方法および組成物
AU2016366680A1 (en) Benzothiophene-based selective estrogen receptor downregulators
JP2011231094A (ja) ブメタニド、フロセミド、ピレタニド、アゾセミド、およびトルセミドのアナログ、組成物および使用方法
CN113924295A (zh) 激酶抑制剂
Zhu et al. Discovery of a novel vascular disrupting agent inhibiting tubulin polymerization and HDACs with potent antitumor effects
JP2008535836A5 (https=)
CN112513057A (zh) 供在由衰老细胞引起或介导的状况的临床管理中使用和用于治疗癌症的作为Bcl家族拮抗剂的酰基氨基膦酸酯和酰基苄胺
US10918657B2 (en) Treatment of spinal cord injury or traumatic brain injury by inhibition of synuclein protein aggregation
JPWO2007020935A1 (ja) Ｐ２ｙ１２受容体および／またはｐ２ｙ１４受容体ブロッカーを含有してなる疼痛治療剤
EP1937242A2 (en) Methods and compositions for the treatment of neuropsychiatric and addictive disorders
US12070463B2 (en) Compositions and methods for the treatment of seizure caused by brain tumor
CA2625362A1 (en) Methods and compositions for the treatment of neuropsychiatric and addictive disorders
MX2008004951A (en) Methods and compositions for the treatment of neuropsychiatric and addictive disorders
CA2604446A1 (en) Methods and compositions for the treatment of anxiety disorders